2 October 2026
Learn about Vitality's GLP-1 obesity support and how it supports successful weight loss through assessments and personalised programs.
18 September 2026
GLP-1 medicines alone can't solve SA's diabetes crisis, experts warn, urging earlier screening, coordinated care and better food access.
24 July 2026
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
23 July 2026
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.
21 July 2026
Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.
21 July 2026
The Extensior South Africa launch on 27 July, offering patients a lower-cost, authorised semaglutide treatment for type 2 diabetes.
13 July 2026
Telehealth GLP-1 prescribing practices may expose patients to unsafe care, weak medical checks and compounded weight-loss drugs.
10 July 2026
Aspen Chair Transition will see Ben Kruger replace Kuseni Dlamini as Aspen Pharmacare prepares for debt-free growth and new investment.
3 March 2026
Explore the Dis-Chem Better Rewards Programme and discover how it boosts revenue by 10% with integrated rewards and services.